Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 2 Hodgkin Disease 1

Interventions

fludarabine phosphate 90 Cyclophosphamide 85 Mycophenolic Acid 67 Peripheral Blood Stem Cell Transplantation 65 Whole-Body Irradiation 59 Tacrolimus 58 Cyclosporine 46 Busulfan 45 Antilymphocyte Serum 39 fludarabine 35 Filgrastim 35 Melphalan 33 Methotrexate 28 Radiotherapy 26 Granulocyte Colony-Stimulating Factor 20 Sirolimus 17 Methylprednisolone 17 Etoposide 17 Cord Blood Stem Cell Transplantation 17 Rituximab 14 Stem Cell Transplantation 13 Alemtuzumab 13 thymoglobulin 11 sargramostim 11 Cyclosporins 11 Therapeutics 10 Flow Cytometry 10 Cytarabine 10 plerixafor 8 Thiotepa 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Lenograstim × Plasma cell × Clear all

NCT01085058 2010-03-11

CU01

WiSP Wissenschaftlicher Service Pharma GmbH

Phase 2/3 Completed

LymphoidPlasma cell

Hodgkin Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡